Pacific Biosciences of California, Inc.
PACB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$310 | -$307 | -$314 | -$181 |
| Dep. & Amort. | $53 | $33 | $17 | $12 |
| Deferred Tax | -$0 | -$11 | $0 | -$94 |
| Stock-Based Comp. | $0 | $0 | $79 | $81 |
| Change in WC | -$41 | -$59 | -$54 | $21 |
| Other Non-Cash | $91 | $78 | $9 | $50 |
| Operating Cash Flow | -$206 | -$267 | -$263 | -$111 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$9 | -$17 | -$6 |
| Net Acquisitions | $0 | -$0 | $0 | -$320 |
| Inv. Purchases | -$499 | -$757 | -$443 | -$988 |
| Inv. Sales/Matur. | $629 | $770 | $576 | $635 |
| Other Inv. Act. | $0 | $0 | -$0 | $0 |
| Investing Cash Flow | $124 | $5 | $116 | -$679 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$51 | -$2 | -$2 | $895 |
| Stock Issued | $8 | $205 | $11 | $295 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$86 | $0 | -$20 |
| Financing Cash Flow | -$43 | $116 | $10 | $1,170 |
| Forex Effect | $1 | $1 | $0 | $0 |
| Net Chg. in Cash | -$124 | -$145 | -$138 | $380 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $180 | $325 | $466 | $86 |
| End Cash | $56 | $180 | $328 | $466 |
| Free Cash Flow | -$212 | -$275 | -$280 | -$117 |